Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;54(2):189-94.
doi: 10.1016/j.bcmd.2014.11.003. Epub 2014 Nov 24.

Pulmonary hypertension in well-transfused thalassemia major patients

Affiliations

Pulmonary hypertension in well-transfused thalassemia major patients

Antonella Meloni et al. Blood Cells Mol Dis. 2015 Feb.

Abstract

The risk for pulmonary hypertension (PH) in thalassemia major (TM) patients remains controversial. We report echocardiography results from 60 TM patients: we evaluated the association between tricuspid regurgitation velocities (TRV), iron stores, and serologic markers of hemolysis and arginine dysregulation. Patients were enrolled from August 2004 until May 2009. All parameters were inversely weighted by the number of exams. TRV was comparable between sexes and it was uncorrelated with age. At the first exam, TR velocities at the upper limits of normal (2.5-2.7m/s) were observed in 8 patients. An abnormal TRV (2.9m/s) was found in 1 patient. Borderline increases in TRV were associated with a reduced global arginine bioavailability (R=-0.399 P=0.005), increased anemia (hemoglobin: R=-0.219 P=0.0461), cardiac index (R=0.223 P=0.0481), and diastolic dysfunction (E/A: R=0.289 P=0.0088; E/E': R=0.223 P=0.0453), but not hemolysis, iron overload and systolic function evaluated by Magnetic Resonance Imaging, and splenectomy. Well-transfused TM patients have a lower risk for PH than thalassemia intermedia patients. However, they do have vascular stressors that raise their lifetime PH risk to levels higher than for the general population. Consequently, we support recommendations for annual echocardiographic screening and cardiac catheterization for persistent TRV above 3m/s.

Keywords: Echocardiography; Risk for pulmonary hypertension; Thalassemia major; Tricuspid regurgitant jet velocity.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

Dr Pepe has received speaker honoraria from Chiesi Farmaceutici, ApoPharma Inc. and Novartis. Dr. Harmatz has received research funding, honorarium and/or provided consulting support to Shire, BioMarin, Alexion, Novartis, and Genzyme. Dr Wood and Dr Coates receive research funding from Shire. Dr Wood is MRI consultant for Shire, Biomed Informatics, and ApoPharma.

Figures

Figure 1
Figure 1
Scatter plot and fitted regression line showing the relationship between TRV and global arginine bioavailability (GAB). Thresholds proposed by Morris et al. are shown; no patient has decreased GAB.
Figure 2
Figure 2
Scatter plot and fitted regression line showing the relationship between TRV and hemoglobin (up) and between TRV and cardiac index (bottom).
Figure 3
Figure 3
Scatter diagram and regression line of TRV compared to E/A ratio (up) and E/E′ ratio (bottom); E/E′ > 10 is considered evidence of diastolic dysfunction.

Similar articles

Cited by

References

    1. McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation. 2006;114:1417–1431. - PubMed
    1. Habib G, Torbicki A. The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension. Eur Respir Rev. 2010;19:288–299. - PMC - PubMed
    1. Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6:359–365. - PubMed
    1. Barnett CF, Hsue PY, Machado RF. Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection. Jama. 2008;299:324–331. - PubMed
    1. Aessopos A, Farmakis D. Pulmonary hypertension in beta-thalassemia. Ann N Y Acad Sci. 2005;1054:342–349. - PubMed

Publication types

MeSH terms